| Name | Title | Contact Details |
|---|
Stilla Technologies is a leading global biotechnology company that focuses on accelerating development of next-generation genetic testing by providing researchers and clinicians with a flexible Digital PCR solution for high-resolution genetic analysis and assay development. Stilla`s next-generation Multiplex Crystal Digital PCR™ technology employs cutting-edge microfluidic innovations and integrates the entire dPCR process on a single chip. The naica® system is highly sensitive, fast, and features an easy workflow, higher levels of multiplexing, and intuitive software. Stilla developed the world`s first 6-color Digital PCR Platform, providing High Multiplexing and Sensitivity for Advancing Cancer & Liquid Biopsy Studies, Cell & Gene Therapies, Infectious Disease & COVID-19 Research, and Wastewater and Environmental Testing and many more applications. Stilla aims to make Digital PCR a lab commodity in all life sciences areas including research, therapeutics, and the omics.
AccelBeam Synthesis, Inc. is a Garnet Valley, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
DripDrop is an oral rehydration therapy, based in San Francisco, California.
Sensei is an evidenced-based company that develops technology and offers healthier living programs and services to help people find greater wellbeing. Its first retreat is located at the Sensei Lānaʻi, A Four Seasons Resort on Larry Ellison`s secluded Hawaiian island of Lānaʻi, is where people come to learn the Sensei Way philosophy in the most luxurious and inspiring settings. Each guest`s stay is highly customized to help align their actions with their intentions by offering private wellness consultations, small indoor and outdoor classes, relaxing treatments in individual spa hales, outdoor adventures and innovative dining guided by the Sensei nutritional philosophy.
Toronto-based digital health firm BlueDot, has developed a first-of-its-kind, global early warning technology for infectious diseases. Using artificial and human intelligence, BlueDot`s outbreak risk platform tracks over 150 infectious diseases globally in 65 languages, around the clock and anticipates their spread and impact. They empower national and international health agencies, hospitals, and businesses to better anticipate, and respond to, emerging threats.